Faeth Therapeutics

Yahoo Finance • 22 days ago

Faeth gets new Buy at Guggenheim on lead asset

[Wall Street sign in Lower Manhattan, NYC] georgeclerk * Guggenheim has launched its coverage of cancer drug developer Faeth Therapeutics (FTH [https://seekingalpha.com/symbol/FTH]) with a Buy rating and a $70 price target, citing its l... Full story